Pharmafile Logo
Pharmafocus logo
Advanced Search
lilly corporate hq image

Lilly suffers late-stage cancer blow

September 10, 2012
Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …

News
merck kgaa image

Merck KGaA licences new cancer candidate

September 10, 2012
Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology

Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …

News

Kantar appoints Graeme Jacombs head of APMEA region

September 7, 2012
Sales and Marketing Kantar Health

Consultancy and market research firm Kantar Health has promoted Graeme Jacombs to Managing Director of the Asia Pacific, Middle East …

Appointment

Boehringer signs diabetes research deal

September 7, 2012
Sales and Marketing Boehringer, diabetes, obesity

Boehringer Ingelheim has signed a four-year research agreement with a top Swiss university to look at the underlying causes of …

News

Novartis to file for new Lucentis indication

September 7, 2012
Lucentis, Novartis, macular edema, macular oedema, ophthamology

Novartis is set to file eye treatment Lucentis for a new indication. The firm will submit Lucentis (ranibizumab) to the …

News

New product launches – maximise your chance of success

September 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch

You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …

Feature

Brazil delays excipient GMP deadline

September 6, 2012
Manufacturing and Production ANVISA, Brazil, GMP

Brazil’s national medicines regulatory agency ANVISA has delayed proposed new rules on good manufacturing practice (GMP) for pharmaceutical excipients after …

News

Hospira buys Indian antibiotic plant

September 6, 2012
Manufacturing and Production Hospira, India

US injectable drugs specialist Hospira has announced plans to expand in India via the purchase of a manufacturing facility and …

News
fda_sign_web

Double approval for Pfizer cancer drugs

September 6, 2012
Sales and Marketing CML, Cancer, Glivec, Pfizer, axitinib, rcc

 Two cancer drugs from Pfizer have been approved, one in Europe for kidney cancer and another in the US for …

News

Merck KGaA cuts over 10% of German workforce

September 5, 2012
Research and Development

Merck KGaA is to get rid of more than 10% of its workforce in Germany over the next three years …

News

Pharma welcomes Hunt to top health job

September 5, 2012
Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform

The ABPI has used health secretary Andrew Lansley’s demotion at prime minister David Cameron’s first major cabinet reshuffle to restate …

News

Pfizer to develop phase II cancer vaccine

September 4, 2012
Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine

Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …

News

Valeant to buy dermatogy firm Medicis

September 4, 2012
Sales and Marketing Valeant

Speciality pharma company Valeant is to acquire dermatology-focused Medicis for $2.6 billion.Medicis’ portfolio includes ‘cosmaceutical’ prescription brands such as Solodyn, …

News

Contract research news in brief

September 4, 2012
Research and Development CRO, Charles River, WuXi

 Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …

News

Genzyme recalls drug on failed stability testing

September 4, 2012
Manufacturing and Production Genzyme, Stability Testing, pharma recalls

Sanofi subsidiary Genzyme has recalled nine lots of its transplant drug Thymoglobulin in the US after stability testing revealed there …

News

Cash incentive for NHS digital info sharing

September 3, 2012
NHS, digital

NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …

News

Cash incentive for NHS digital info sharing

September 3, 2012
NHS, digital

NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …

News
Novartis

Novartis cheered by COPD trial results

September 3, 2012
Research and Development COPD, ERS, Novartis

One of Novartis’ experimental respiratory drugs has proved superior in a late-stage trial to Boehringer Ingelheim and Pfizer’s existing brand …

News
db3

The ex-CEO’s Job Blog – part 1

September 3, 2012
Medical Communications David Barratt, Jobs, careers, pharma jobs, restructuring, the ex-CEO's job blog

I have seen a lot in my healthcare career. Been round the block more than twice, as they say. I …

Feature

New quad HIV pill passed by FDA

September 2, 2012
Sales and Marketing FDA, Gilead, HIV, stribild

Gilead’s four-in-one anti-HIV once-daily pill Stribild has been given the green light by the FDA for adults who have not …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026